Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.
about
Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma.Arming cytokine-induced killer cells with chimeric antigen receptors: CD28 outperforms combined CD28-OX40 "super-stimulation".Broadening the repertoire of melanoma-associated T-cell epitopes.Trial Watch: Adoptive cell transfer immunotherapy.Tumor-infiltrating lymphocytes in melanoma.Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients.Trial Watch: Adoptive cell transfer for anticancer immunotherapy.Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.Systematic evaluation of immune regulation and modulationAchievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?Predictors of tumor-infiltrating lymphocyte efficacy in melanoma.Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes.Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model.Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes.BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer.Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting.Trial Watch: Adoptive cell transfer for anticancer immunotherapy.Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction.Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site
P2860
Q33688931-E49D4B4E-CC7B-4BCD-BA7F-CB0755C7B07EQ34367252-B74BA398-95C3-4110-B61E-3C60A6551269Q35546276-FFCF9DB5-F82F-4AFD-BC05-497818557C98Q36057432-098C0ADA-D534-44E5-B7F3-2055A2F537E9Q36292200-7EA10EFB-46D5-4675-A417-096947CE60B5Q36444798-F03B8398-E2BD-4845-AEBC-2C7998FD4C5CQ36887833-6AEABA80-E1B3-48BB-8DC7-CCA98B7B1F24Q37065838-DB2A0569-E606-411B-A0A6-E5B47A496934Q37713498-020948B5-FF68-4AB2-86EA-8EA3B8F76CE2Q38237522-DA2EE6D7-856D-4545-B15C-8348702DA9B8Q38665128-0AAAD6E2-9745-4AAE-88B0-991660EB8435Q40603434-045AB288-D5C2-4420-968A-6705FB0BA0D5Q41915301-D5E0CB64-66B2-424F-9F57-E61E352467D6Q42403183-0842A6CA-BA19-476B-99D5-CD7BB6E6492EQ42417533-758BEF84-8B91-4448-B453-7B1586425235Q42695310-FFD8AF89-B67E-44BC-9359-28ED53727D93Q42702234-2231087B-8DAD-4910-88E6-5CF80BE90E95Q54965630-1AEF3F33-7301-4DB0-902F-B9A3F1332B6DQ58768316-D5032546-E7A3-4754-90EC-625A18E06EA2
P2860
Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Characterization and compariso ...... lational research institution.
@en
Characterization and compariso ...... lational research institution.
@nl
type
label
Characterization and compariso ...... lational research institution.
@en
Characterization and compariso ...... lational research institution.
@nl
prefLabel
Characterization and compariso ...... lational research institution.
@en
Characterization and compariso ...... lational research institution.
@nl
P2860
P50
P1476
Characterization and compariso ...... slational research institution
@en
P2093
E Ellebaek
P T Straten
P2860
P304
P356
10.1111/J.1365-3083.2011.02640.X
P577
2012-02-01T00:00:00Z